Stonepine Capital Management, LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Stonepine Capital Management, LLC disclosed 58 US equity positions worth $101.5m in its Q2 2025 13F filing. The largest position was ADMA at 13.5% of the reported book, followed by EOLS and ZVRA. Against the Q1 2025 filing, it opened 15 new positions, added to 23 and reduced 12 among the top 50 holdings.
What did Stonepine Capital Management, LLC own in Q2 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ADMA ADMA BIOLOGICS INC | Healthcare | 13.5% | $13.7m | 750,000 | -7% | reduced |
| 2 | EOLS EVOLUS INC | Healthcare | 8.3% | $8.4m | 916,500 | -19% | reduced |
| 3 | ZVRA ZEVRA THERAPEUTICS INC | 6.7% | $6.8m | 775,620 | 19% | added | |
| 4 | VSTM VERASTEM INC | Healthcare | 5.6% | $5.6m | 1,360,386 | 122% | added |
| 5 | INDIVIOR PLC | 5.1% | $5.2m | 350,000 | 15% | added | |
| 6 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 4.8% | $4.9m | 225,000 | 141% | added |
| 7 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 4.5% | $4.6m | 604,066 | 2% | added |
| 8 | TELA TELA BIO INC | 4.0% | $4.0m | 2,083,762 | 1% | added | |
| 9 | XOMA ROYALTY CORPORATION | 3.8% | $3.8m | 152,143 | 17% | added | |
| 10 | 2662247D ITEOS THERAPEUTICS INC | 3.0% | $3.1m | 310,033 | 182% | added | |
| 11 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 2.9% | $2.9m | 450,000 | 29% | added | |
| 12 | SRZN SURROZEN INC | 2.7% | $2.7m | 306,029 | 7% | added | |
| 13 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 2.5% | $2.5m | 38,597 | -20% | reduced |
| 14 | ARDX ARDELYX INC | Healthcare | 2.1% | $2.2m | 555,000 | – | new |
| 15 | ANIK ANIKA THERAPEUTICS INC | Healthcare | 2.0% | $2.0m | 190,590 | -8% | reduced |
| 16 | AYTU AYTU BIOPHARMA INC | 1.7% | $1.8m | 812,676 | 75% | added | |
| 17 | IKT INHIBIKASE THERAPEUTICS INC | 1.4% | $1.4m | 733,793 | -20% | reduced | |
| 18 | GERN GERON CORP | Healthcare | 1.4% | $1.4m | 1,000,000 | 100% | added |
| 19 | HRTX HERON THERAPEUTICS INC | Healthcare | 1.3% | $1.4m | 657,380 | -17% | reduced |
| 20 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.3% | $1.3m | 50,200 | – | new |
| 21 | YMABUSD Y-MABS THERAPEUTICS INC | 1.3% | $1.3m | 285,300 | 118% | added | |
| 22 | COLL COLLEGIUM PHARMACEUTICAL INC | Healthcare | 1.2% | $1.2m | 41,500 | 101% | added |
| 23 | VNDA VANDA PHARMACEUTICALS INC | Healthcare | 1.2% | $1.2m | 250,000 | 611% | added |
| 24 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.1% | $1.1m | 100,000 | 364% | added | |
| 25 | ALMS ALUMIS INC | 1.0% | $1.0m | 349,615 | – | new | |
| 26 | MYO MYOMO INC | 1.0% | $988.0k | 457,419 | 65% | added | |
| 27 | RZLT REZOLUTE INC | 1.0% | $976.7k | 219,000 | – | new | |
| 28 | XERS XERIS BIOPHARMA HOLDINGS INC | Healthcare | 0.9% | $957.8k | 205,100 | 101% | added |
| 29 | PMVP PMV PHARMACEUTICALS INC | 0.9% | $896.7k | 845,968 | 34% | added | |
| 30 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 0.9% | $870.0k | 92,900 | – | new |
| 31 | GRCE GRACE THERAPEUTICS INC | 0.9% | $868.7k | 292,500 | -1% | reduced | |
| 32 | 2KZ0 KEZAR LIFE SCIENCES INC | 0.8% | $778.0k | 169,859 | 70% | added | |
| 33 | ANGO ANGIODYNAMICS INC | Healthcare | 0.8% | $765.2k | 77,141 | – | new |
| 34 | ACHV ACHIEVE LIFE SCIENCES INC | 0.7% | $753.3k | 333,333 | – | new | |
| 35 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 0.7% | $697.6k | 491,300 | -7% | reduced |
| 36 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 0.6% | $655.2k | 130,000 | -10% | reduced |
| 37 | BIOA BIOAGE LABS INC | 0.6% | $624.0k | 151,085 | 202% | added | |
| 38 | LQDA LIQUIDIA CORPORATION | Healthcare | 0.6% | $623.0k | 50,000 | – | new |
| 39 | ANTX AN2 THERAPEUTICS INC | 0.6% | $577.2k | 544,494 | – | new | |
| 40 | KPRX KIORA PHARMACEUTICALS INC | 0.5% | $512.6k | 178,000 | -11% | reduced | |
| 41 | SPRO SPERO THERAPEUTICS INC | Healthcare | 0.4% | $455.0k | 156,888 | – | new |
| 42 | HILLEVAX INC | 0.4% | $449.8k | 226,009 | -5% | reduced | |
| 43 | THERATECHNOLOGIES INC | 0.4% | $446.2k | 189,051 | 632% | added | |
| 44 | LUNG PULMONX CORP | Healthcare | 0.4% | $377.9k | 145,900 | – | new |
| 45 | HCAT HEALTH CATALYST INC | Healthcare | 0.4% | $377.0k | 100,000 | – | new |
| 46 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 0.3% | $299.0k | 7,000 | -91% | reduced |
| 47 | DVAX DYNAVAX TECHNOLOGIES CORP | 0.3% | $297.6k | 30,000 | – | new | |
| 48 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 0.3% | $255.6k | 45,000 | – | new |
| 49 | SVRA SAVARA INC | Healthcare | 0.2% | $193.8k | 85,000 | 192% | added |
| 50 | INAB IN8BIO INC | 0.2% | $172.3k | 82,430 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.